GQG Partners LLC Has $537.73 Million Stock Holdings in Humana Inc. (NYSE:HUM)

GQG Partners LLC lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 5.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,214,981 shares of the insurance provider’s stock after buying an additional 65,817 shares during the period. Humana comprises 1.6% of GQG Partners LLC’s holdings, making the stock its 25th largest position. GQG Partners LLC’s holdings in Humana were worth $537,733,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. E Fund Management Co. Ltd. bought a new stake in shares of Humana in the 1st quarter valued at about $195,000. Quilter Plc bought a new stake in shares of Humana in the 1st quarter valued at about $263,000. Prudential Financial Inc. raised its holdings in shares of Humana by 25.5% in the 1st quarter. Prudential Financial Inc. now owns 157,459 shares of the insurance provider’s stock valued at $66,014,000 after purchasing an additional 32,029 shares during the period. Moors & Cabot Inc. raised its holdings in shares of Humana by 11.4% in the 1st quarter. Moors & Cabot Inc. now owns 1,431 shares of the insurance provider’s stock valued at $600,000 after purchasing an additional 147 shares during the period. Finally, Cresset Asset Management LLC raised its holdings in shares of Humana by 82.1% in the 1st quarter. Cresset Asset Management LLC now owns 1,704 shares of the insurance provider’s stock valued at $716,000 after purchasing an additional 768 shares during the period. Institutional investors own 91.85% of the company’s stock.

Shares of HUM traded up $13.42 during mid-day trading on Thursday, hitting $434.11. 25,958 shares of the company’s stock were exchanged, compared to its average volume of 896,439. Humana Inc. has a 52 week low of $370.22 and a 52 week high of $475.44. The stock’s 50-day simple moving average is $406.80 and its 200-day simple moving average is $428.72. The firm has a market cap of $55.79 billion, a price-to-earnings ratio of 22.83, a price-to-earnings-growth ratio of 1.42 and a beta of 0.89. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.41.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 28th. The insurance provider reported $6.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $6.86 by $0.03. Humana had a net margin of 3.09% and a return on equity of 13.62%. The company had revenue of $20.65 billion for the quarter, compared to analysts’ expectations of $20.51 billion. Analysts forecast that Humana Inc. will post 21.49 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 29th. Investors of record on Thursday, September 30th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Wednesday, September 29th. This represents a $2.80 annualized dividend and a dividend yield of 0.64%. Humana’s dividend payout ratio is 14.93%.

A number of brokerages have recently issued reports on HUM. Barclays began coverage on shares of Humana in a report on Thursday, September 9th. They issued an “overweight” rating and a $500.00 target price on the stock. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $490.00 target price on the stock in a report on Friday, July 16th. Morgan Stanley increased their price target on shares of Humana from $500.00 to $513.00 and gave the company an “overweight” rating in a report on Tuesday, August 31st. SVB Leerink began coverage on shares of Humana in a report on Monday, September 27th. They issued an “outperform” rating and a $494.00 price target on the stock. Finally, Seaport Res Ptn reissued a “neutral” rating on shares of Humana in a report on Friday, July 9th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $486.92.

In related news, Director David A. Jr/Ky Jones sold 4,800 shares of the stock in a transaction that occurred on Thursday, September 16th. The shares were sold at an average price of $401.00, for a total transaction of $1,924,800.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.40% of the company’s stock.

Humana Company Profile

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts.

Further Reading: Green Investing

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.